News & Updates

New drug applications approved by US FDA as of 1-15 September 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A closer look at antibiotic prescribing practices for childhood illnesses in Singapore uncovers opportunities for improvement, even when overall rates seem appropriate.

Metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) may predispose affected individuals to liver and gastrointestinal cancers, as reported in a study.

Cannabinoids for medical purposes in children and adolescents have been linked to increased risk of adverse events (AEs), according to the results of a meta-analysis.

Disorders of gut-brain interaction during childhood may continue until adulthood in some patients, reveals a study, noting that management monitoring should persist into adulthood.

Patients with Crohn’s disease who underwent early ileal resection are not at increased risk of a repeat resection, according to a retrospective study.

Eating nuts appears to confer some benefits on a person’s body fat distribution and gut microbiota diversity and taxonomy, suggest the results a recent study.